OBJECTIVE: To evaluate the functional outcome after seton treatment of high transsphincteric anal fistulas. DESIGN: Retrospective study. SETTING: University hospital, Sweden. SUBJECTS: 29 patients (8 women, mean age 46, range 25-71) with high transsphincteric anal fistulas 1983-1992. INTERVENTIONS: Setons were inserted in the anal fistulas in all patients. MAIN OUTCOME MEASURES: Anal continence evaluated by a questionnaire a mean of 46 months postoperatively. Clinical data were collected from the patients' records. RESULTS: All four patients with inflammatory bowel disease had some incontinence. Of the remaining 25 patients, 11 (44%) complained of incontinence and 2 (8%) developed recurrent fistulas. Incontinence was more common when the seton was tightened at the last procedure (7/9) compared with those in which the tissue enclosed by the seton was divided (4/16, p = 0.03). No other preoperative or operative characteristic significantly influenced the risk of incontinence. CONCLUSION: Incontinence is common after seton treatment of high transsphincteric anal fistulas. The risk seems to be higher when the muscle remains viable after a period of seton treatment.
OBJECTIVE: To evaluate the functional outcome after seton treatment of high transsphincteric anal fistulas. DESIGN: Retrospective study. SETTING: University hospital, Sweden. SUBJECTS: 29 patients (8 women, mean age 46, range 25-71) with high transsphincteric anal fistulas 1983-1992. INTERVENTIONS: Setons were inserted in the anal fistulas in all patients. MAIN OUTCOME MEASURES: Anal continence evaluated by a questionnaire a mean of 46 months postoperatively. Clinical data were collected from the patients' records. RESULTS: All four patients with inflammatory bowel disease had some incontinence. Of the remaining 25 patients, 11 (44%) complained of incontinence and 2 (8%) developed recurrent fistulas. Incontinence was more common when the seton was tightened at the last procedure (7/9) compared with those in which the tissue enclosed by the seton was divided (4/16, p = 0.03). No other preoperative or operative characteristic significantly influenced the risk of incontinence. CONCLUSION:Incontinence is common after seton treatment of high transsphincteric anal fistulas. The risk seems to be higher when the muscle remains viable after a period of seton treatment.
Authors: Andreas Ommer; Alexander Herold; Eugen Berg; Alois Fürst; Marco Sailer; Thomas Schiedeck Journal: Dtsch Arztebl Int Date: 2011-10-21 Impact factor: 5.594
Authors: S Chan; J McCullough; A Schizas; P Vasas; A Engledow; A Windsor; A Williams; C R Cohen Journal: Tech Coloproctol Date: 2012-04-18 Impact factor: 3.781
Authors: Francisco Perez; Antonio Arroyo; Pilar Serrano; Fernando Candela; Maria-Teresa Perez; Rafael Calpena Journal: Int J Colorectal Dis Date: 2005-10-20 Impact factor: 2.571